We further show that tumours that are otherwise 'immunologically hot' tend to display higher levels of the C-ECM-up programme and possess genomic alterations that may minimise the fitness costs of the high levels of TGF-β signalling required to sustain the C-ECM-up programme. This evidence concerns the gene TGFB1 and neoplasm.